Dissolution with immediate closure of the liquidation
Dissolved and wound up in a single deed · Director discharge: Scaldino · Director discharge: Quaestum · General meeting of 29-08-2025 · Gazette deed
New director
BV Scaldino appointed, BV B-Epic resigned · Permanent representative: Van Overschelde Philippe · Director discharge: BV B-Epic (director (not named in the articles)) · General meeting of 17-01-2054 · Gazette deed
New director
Quaestum appointed, Delta Rho resigned · Issue of 400,000 shares · Permanent representatives: Dimitri Roose and Claikens Bart · General meeting of 22-02-2022 · Gazette deed
Incorporation
Founding capital of €86,000, €10,000 paid up · Founders: Peerlinck, Hans Marcel Adolf; Goossens, Sander Frans Eliza; Roose, Dimitri Owen Bernard Antoine Oswald; and 3 others · Appointments: HP Projects, Delta Rho and B-Epic · Gazette deed
“Het ontwikkelen van software en producten in de breedste zin van het woord” (deed in Dutch)From the articles, 19 activitiesNo NACE code in the KBO yet
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2023
MEDCAP had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does MEDCAP fall under?
In its 2023 annual accounts, MEDCAP states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of MEDCAP?
The turnover in financial year 2024 is ≈ €440,000. This figure is estimated from the gross margin of €176,487 and 2,207 comparable companies of the same size. It probably lies between €290,000 and €680,000. It is a rough estimate.
Is MEDCAP profitable?
In financial year 2024, MEDCAP made a profit of €123,331.
Where can I find the annual accounts of MEDCAP?
MEDCAP filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2024.